Oral candidosis in HIV-infected patients
Gazzard, B.G.; Smith, D.
British Journal of Clinical Practice. Supplement 71: 103-108
1990
ISSN/ISBN: 0262-8767 PMID: 2091730 Document Number: 366004
Oral Candida infections in HIV-positive patients are discussed. Incidence, diagnosis, types of buccal candidosis, pathogenesis and treatment are considered.
Document emailed within 1 workday
Related Documents
Aanpreung, P.; Veerakul, G. 1997: Itraconazole for treatment of oral candidosis in pediatric cancer patients Journal of the Medical Association of Thailand 80(6): 358-362Ivanyi, L.; Wong, W.K. 1992: Elevated IgA salivary antibody levels to mycobacterial 65 kDa stress protein in patients with oral candidosis Folia Biologica 38(3-4): 263-268
Cornejo, L.S.; López de Blanc, S.; Femopase, F.; Azcurra, A.; Calamari, S.; Battellino, L.J.; Dorronsoro de Cattoni, S.T. 1998: Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin Acta Odontologica Latinoamericana: Aol 11(1): 15-25
Tao, R.-C.; Chen, B.; Li, Y.-L.; Ma, F. 2010: Logistic regression analysis for the risk factors of oral candidosis among patients with non-insulin dependent diabetes mellitus Hua Xi Kou Qiang Yi Xue Za Zhi 28(1): 41-44
Sadek, S.; Mostafa, M.H.; Radwan, Z. 1980: Oral and cutaneous candidosis in Saudi Arabian newborn infants Egyptian Dental Journal 26(1): 73-86
Hermann, P.; Berek, Z.; Kamotsay, K.; Nagy, G.; Rozgonyi, F. 2001: Clinical, microbiological and therapeutic aspects of oral candidiasis (candidosis) Orvosi Hetilap 142(48): 2667-2671
Gupta, P.; Faridi, M.M.; Rawat, S.; Sharma, P. 1996: Clinical profile and risk factors for oral candidosis in sick newborns Indian Pediatrics 33(4): 299-303
Anonymous 1989: International Workshop on oral and gastrointestinal candidosis: from pathology to therapy, Munich, May 27, 1989 Mycoses 32(Suppl 2): 6-64
Gallè, F.; Sanguinetti, M.; Colella, G.; Di Onofrio, V.; Torelli, R.; Rossano, F.; Liguori, G. 2011: Oral candidosis: characterization of a sample of recurrent infections and study of resistance determinants New Microbiologica 34(4): 379-389
Ziino, L.; Meli, F. 1975: Methyl-partricin in the treatment of candidosis of the oral cavity in infants. Controlled research Minerva Pediatrica 27(36): 2030-2033
Jensen, T.O.; Tam, V.V.; Mai, N.T.; Ut, D.Q.; Dat, D.D.; Lien, N.T.; Nga, N.T.; Bygbjerg, I.C. 2005: Oral and constitutional manifestations of HIV-infected hospital patients in Northern Vietnam Southeast Asian Journal of Tropical Medicine and Public Health 36(6): 1459-1468
Sindrup, J.H.; Weismann, K.; Sand Petersen, C.; Rindum, J.; Pedersen, C.; Mathiesen, L.; Worm, A.M.; Kroon, S.; Søndergaard, J.; Lange Wantzin, G. 1988: Skin and oral mucosal changes in patients infected with human immunodeficiency virus Acta Dermato-Venereologica 68(5): 440-443
Agwu, E.; Ihongbe, J.C.; Pazos, V.; Tirwomwe, J.F. 2009: Zero prevalence of parasites associated with oral lesions of HIV infected and AIDS patients in South Western Uganda African Health Sciences 9(4): 258-263
Costa, C.R.; de Lemos, J.A.; Passos, X.S.; de Araújo, C.R.; Cohen, A.J.; Souza, L.úc.K.H.E.; Silva, M.d.R.ár.R. 2006: Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era Mycopathologia 162(1): 45-50
Walli, R.; Herfort, O.; Michl, G.M.; Demant, T.; Jäger, H.; Dieterle, C.; Bogner, J.R.; Landgraf, R.; Goebel, F.D. 1998: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients Aids 12(15): F167-F173
Roberts, R.B.; Dickinson, G.M.; Heseltine, P.N.; Leedom, J.M.; Mansell, P.W.; Rodriguez, S.; Johnson, K.M.; Lubina, J.A.; Makuch, R.W. 1990: A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. the Ribavirin-LAS Collaborative Group Journal of Acquired Immune Deficiency Syndromes 3(9): 884-892
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Goni, B.W.; Yusuph, H.; Mustapha, S.K.; Sahabi, M.A.; Gwalabe, S.A.; Tahir, A.; Bakki, B.; Kida, I.M. 2013: Hepatic transaminase and alkaline phosphatase enzyme levels in HIV/HBV co-infected and HIV mono-infected patients in Maiduguri, Nigeria Nigerian Journal of Clinical Practice 16(4): 530-534
Miró Meda, J.M.; Mallolas Masferrer, J.; Moreno-Camacho, A.; Marco Reverter, F.; García Alcaide, F. 1997: Cryptococcus neoformans infections in patients infected and not infected with HIV Revista Clinica Espanola 197(Suppl): 49-59
Jemli, B.; Aouni, Z.; Lebben, I.; Mazigh, C.; Ferjani, M.; Machgoul, M.; Gargouri, S. 2007: Procalcitonin in invasive candidosis Annales de Biologie Clinique 65(2): 169-173